Francisco
Marin Ortuño
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
Jose Miguel
Rivera Caravaca
Profesor Permanente Laboral
Publications by the researcher in collaboration with Jose Miguel Rivera Caravaca (101)
2024
-
Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation
Expert Review of Neurotherapeutics, Vol. 24, Núm. 9, pp. 913-928
-
Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients
Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 835-842
-
Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis
European Journal of Clinical Investigation
-
Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study
Internal and Emergency Medicine
2023
-
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment
American Journal of Cardiology, Vol. 203, pp. 122-127
-
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis
Journal of Clinical Medicine, Vol. 12, Núm. 8
-
Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
Clinical Cardiology, Vol. 46, Núm. 6, pp. 656-662
-
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 8-15
-
High medium-term incidence of major cardiovascular events in discharged patients with unstable angina
IJC Heart and Vasculature, Vol. 46
-
Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis
European Journal of Internal Medicine
-
Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making
American Heart Journal, Vol. 258, pp. 1-16
-
Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review
Science of the Total Environment, Vol. 880
-
Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients
IJC Heart and Vasculature, Vol. 46
-
Incidence and predictors of sternal surgical wound infection in cardiac surgery: A prospective study
International Wound Journal, Vol. 20, Núm. 4, pp. 917-924
-
Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea
FASEB Journal, Vol. 37, Núm. 6
-
Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment
Medicina Clinica, Vol. 161, Núm. 8, pp. 344-350
-
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Biomedicine and Pharmacotherapy, Vol. 158
-
Reducing bleeding risk in patients on oral anticoagulation therapy
Expert Review of Cardiovascular Therapy, Vol. 21, Núm. 12, pp. 923-936
-
Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia
Heart and Lung, Vol. 59, pp. 61-66
-
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
Journal of General Internal Medicine, Vol. 38, Núm. 2, pp. 315-323